What is the effectiveness and price of the Lao version of Seleniso?

The Lao version of Selinexor (Selinexor) is a new type of anti-tumor drug, which belongs to the category of generic drugs. Its drug ingredients are basically the same as those of the original drug, but the manufacturers are different, and there may be differences in specifications, prices, etc. Selinisol is mainly used to treat relapsed or refractory multiple myeloma and diffuse large B-cell lymphoma. This drug plays an anti-tumor effect by inhibiting the XPO1 (Exportin 1) pathway in tumor cells and promoting the apoptosis of cancer cells.

In clinical trials, selinesol has shown efficacy against a variety of tumor types, particularly in patients who have failed to respond to conventional treatments. Regarding the effects of the Lao version of selinesol, current research and clinical applications have shown that the drug can improve patients’ survival rates and quality of life. In some cases, patients treated with selinesol had a higher rate of tumor shrinkage or stabilization and improved survival compared with controls. In addition, selinesol often shows synergistic effects when used in combination with other drugs, which provides patients with more treatment options.

However, the use of selinesol is also associated with some side effects, including fatigue, loss of appetite, nausea, diarrhea, etc. These side effects vary among patients, and some may tolerate them well, while others may require dose adjustment or discontinuation.

The Lao version of selinexol sold in overseas markets is commonly produced by Lucius Pharmaceuticals, Daxiong Pharmaceuticals, etc., with specifications such as 20mg*32 tablets, 20mg*16 tablets, etc. The price per box is about 2,000-4,000 yuan (the price may fluctuate due to the exchange rate), providing more patients with affordable treatment options.